These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39075884)

  • 1. How to address the complexity of multi-targeted drug discovery for Alzheimer's disease?
    González JF; Sánchez-Montero JM
    Expert Opin Drug Discov; 2024 Oct; 19(10):1149-1152. PubMed ID: 39075884
    [No Abstract]   [Full Text] [Related]  

  • 2. Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches.
    González JF; Alcántara AR; Doadrio AL; Sánchez-Montero JM
    Expert Opin Drug Discov; 2019 Sep; 14(9):879-891. PubMed ID: 31165654
    [No Abstract]   [Full Text] [Related]  

  • 3. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease.
    Camins A; Ettcheto M; Busquets O; Manzine PR; Castro-Torres RD; Beas-Zarate C; Verdaguer E; Sureda FX; Bulló M; Olloquequi J; Auladell C; Folch J
    Expert Opin Investig Drugs; 2019 Jan; 28(1):93-97. PubMed ID: 30480461
    [No Abstract]   [Full Text] [Related]  

  • 5. Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
    Cacabelos R
    Expert Opin Drug Discov; 2018 Jun; 13(6):523-538. PubMed ID: 29607687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery, development and delivery in Alzheimer's disease.
    Brambilla D
    Pharm Res; 2017 Dec; 35(1):3. PubMed ID: 29288429
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetic drugs for Alzheimer's disease.
    Peedicayil J
    Br J Clin Pharmacol; 2013 Apr; 75(4):1152-3. PubMed ID: 22905989
    [No Abstract]   [Full Text] [Related]  

  • 9. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

  • 10. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 11. Artificial intelligence for drug discovery and development in Alzheimer's disease.
    Qiu Y; Cheng F
    Curr Opin Struct Biol; 2024 Apr; 85():102776. PubMed ID: 38335558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How efficient are rodent models for Alzheimer's disease drug discovery?
    Guo B; Zhou Q
    Expert Opin Drug Discov; 2018 Feb; 13(2):113-115. PubMed ID: 29082769
    [No Abstract]   [Full Text] [Related]  

  • 13. Advancement of Technology for Drug Discovery and Development - Part II.
    Niu B
    Curr Top Med Chem; 2020; 20(1):3. PubMed ID: 31994458
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment.
    Ke J; Tian Q; Xu Q; Fu Z; Fu Q
    Drug Discov Today; 2021 Aug; 26(8):1991-2002. PubMed ID: 33962036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
    Franco R; Martínez-Pinilla E; Navarro G
    Expert Opin Drug Discov; 2019 Apr; 14(4):327-330. PubMed ID: 30775940
    [No Abstract]   [Full Text] [Related]  

  • 16. A systems approach to drug discovery in Alzheimer's disease.
    Shelanski M; Shin W; Aubry S; Sims P; Alvarez MJ; Califano A
    Neurotherapeutics; 2015 Jan; 12(1):126-31. PubMed ID: 25608936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: new approaches to drug discovery.
    Bolognesi ML; Matera R; Minarini A; Rosini M; Melchiorre C
    Curr Opin Chem Biol; 2009 Jun; 13(3):303-8. PubMed ID: 19467915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
    Wang T; Liu XH; Guan J; Ge S; Wu MB; Lin JP; Yang LR
    Eur J Med Chem; 2019 May; 169():200-223. PubMed ID: 30884327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease.
    Cheng F; Wang F; Tang J; Zhou Y; Fu Z; Zhang P; Haines JL; Leverenz JB; Gan L; Hu J; Rosen-Zvi M; Pieper AA; Cummings J
    Cell Rep Med; 2024 Feb; 5(2):101379. PubMed ID: 38382465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Storck SE; Pietrzik CU
    Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.